ITGAE and neoplasm: The inhibitory protein PD1 was detected on tumor-infiltrating CD103+ T cells in RCC, suggesting that their anti-tumor function is actively suppressed and that these tumor-infiltrating T cells can be targeted by checkpoint inhibitors [80].